Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zawia, A"'
Autor:
Nasser H. Zawia, Foqia Mushtaq, Bothaina Alansi, Anwar Masoud, Gehad M. Subaiea, Syed Waseem Bihaqi
Publikováno v:
Current Alzheimer Research. 15:1114-1122
Background: Previously we have shown that developmental exposure to the heavy metal lead (Pb) resulted in latent cognitive impairment, upregulation of biomarkers and pathology associated with both the tau and amyloid pathways, however, the impact on
Autor:
Syed Waseem Bihaqi, Reem Deeb, Asma Lahouel, Gehad M. Subaiea, Joanna K Chang, A. Masoud, Nasser H. Zawia, Miriam Dash, Aseel Eid, Foqia Mushtaq, Allison Leso
Publikováno v:
Current Alzheimer Research. 15:655-663
Background: Tangles are deposits of hyperphosphorylated tau, which are found in multiple neurodegenerative disorders that are referred to as tauopathies, of which Alzheimer's disease (AD) is the most common. Tauopathies are clinically characterized b
Publikováno v:
Current Alzheimer Research. 9:589-599
Alzheimer's disease (AD) is a leading cause of aging related dementia and has been extensively studied by several groups around the world. A general consensus, based on neuropathology, genetics and cellular and animal models, is that the 4 kDa amyloi
Publikováno v:
Current Alzheimer Research. 8:860-867
Evidence from our laboratory suggests that tolfenamic acid has a potential for slowing the progression of Alzheimer's disease (AD) through lowering cortical levels of the β-amyloid precursor protein (APP) and its pathogenic amyloid beta (Aβ) interm
Publikováno v:
Current Alzheimer Research. 8:385-392
Amyloid beta (Aβ) peptides are related to the pathogenesis of Alzheimers disease (AD). The search for therapeutic strategies that lower these peptides has mainly focused on the proteolytic processing of the β-amyloid precursor protein (APP), and ot
Autor:
Nasser H. Zawia
Publikováno v:
Current Alzheimer Research. 15:399-399
Publikováno v:
Current Alzheimer Research. 4:219-228
Alzheimers disease (AD) is currently the most prominent form of dementia among the elderly. Although AD manifests in late adult life, it is not clear when the disease actually starts and how long the neuropathological processes take to develop AD. Th
Publikováno v:
Current Alzheimer Research. 11:1-1
Accumulating research supports the neuroprotective effects of pomegranate (Punica granatum) juice and extracts against Alzheimer's disease (AD) but there is limited data available in animal models. Here we investigated the effects of a standardized p
Autor:
Nasser H. Zawia, Debomoy K. Lahiri
Publikováno v:
Current Alzheimer Research. 9:525-526